ENTITY
Pharmaron Beijing

Pharmaron Beijing (3759 HK)

147
Analysis
Health CareChina
Pharmaron Beijing Co., Ltd. engages in discovery, development, and manufacturing spectrum for small molecule drugs, cell therapies, and gene therapies as well as providing testing services for medical devices and clinic research. The Company offers laboratory, clinical development, chemistry manufactory and control, and other services. Pharmaron Beijing conducts businesses based in China.
more
Refresh
23 Nov 2020 14:04

Quiddity Weekly H/A: Share Spread Monitor as of 20 Nov 2020

The H-Share/A-Share monitor is published every weekend for the data ending the last trading day of the previous week. It includes all H-Share/A...

Logo
125 Views
Share
bearishJD.com
19 Nov 2020 13:08

Hong Kong IPOs: Lock-Up Expiries

A look at companies that have been listed for nearly six/12 months, as a guide to when insiders/controlling shareholders are permitted to sell,...

Logo
743 Views
Share
14 Nov 2020 17:50

Quiddity Weekly H/A: Share Spread Monitor 13 Nov 2020

The Quiddity H/A-Share Spread Monitor for the week ending 13 November 2020. Momentum on a spread basis continues, but momentum on a sector basis...

Logo
116 Views
Share
08 Nov 2020 20:43

Quiddity Weekly H/​​​A: Share Spread Monitor 6 Nov 2020

H/A spreads saw discounts narrow in what was a great week for a couple of sectors on an outright basis. Southbound inflows continue in financials...

Logo
138 Views
Share
05 Nov 2020 13:09

Tigermed (300347.CN/03347.HK) - Q3 Performance Recovered with Optimistic Future Development

This article analyzed Tigermed's business, growth potential, global layout, equity investment and also made forecast and rating for this company.

Logo
248 Views
Share
x